We describe the principle of a new enzyme-immunoassay, competitive enzyme-linked immunoassay (CELIA), for quantitative measurement of soluble antigens and haptens. Intheassay,bindingofantibody to antigen-immunosorbent is competitively inhibited by the free antigen to be measured. The amount of first antibody bound to the immunosorbent is measured by an enzymatic technique inwhich a heterologous bridging antibody and a soluble antibody! enzyme immune complex are applied in sequence. The soluble complex we used was rabbit antiperoxidase/ horseradishperoxidase.Peroxidase activity isinversely proportional to the concentrationinthe original sample of the substance to be assayed.The enzyme-linked reagents are potentially widely applicable to any substance to be measured. To demonstrate the feasibility of CELIA, we report a preliminarystudy of itsapplicationto the measurement of human chioriogonadotropin in serum and urine. The assay described for this hormone has a working range of 1 to 50 mt. units per milliliter of sample. The technique obviates the disadvantages associated with measurement and handling of radioisotopes in radioimmunoassays and the only major instrumentation required isa centrifuge and a conventionalspectrophotometer.
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The principles underlying measurement of minute quantities of substances in biological fluids by competitive protein-binding assays and radioimmunoassays are well established. Competitive protein-binding assays and radioimmunoassay procedures require that the competing substance (ligand, hapten, or antigen) be labeled with a radioisotope, to achieve the desired specificity and sensitivity.
The use of radioisotopes makes these assays very sensitive, but it also has some inconveniences.
For example, in many instances the labeling process must be frequently repeated because of the lability of the labeled compound or the radioisotope itself. The radioactive label may cause destruction of the antigen molecule, or the labeling process itself may alter the original antigenmolecule. In addition,the methods require expensive and sophisticated counting equipment, radioisotope licensing, and special protective measures for safe handling of the radioactive reagents. radioimmunoassays, respectively. In the direct method the only antibody is coupled to the solid phase Bio-Gel to form the insoluble immunosorbent. The immunosorbent acts to separate the bound from free antigen directly. The indirect method allows enzyme-labeled antigen and unlabeled antigen to react with soluble antibody in the first incubation in a soluble phase. Free antigen is separated from antigen bound to the first antibody by precipitation with a second antibody on a solid-phase immunosorbent (antibody directed against the immunoglobulins of the first antisera coupled to Bio-Gel). Similarly, Van Weemen and Schuurs (12) have reported direct and indirect methods for measurement of human choriogonadotropin (HCG), using HCG conjugated with horseradish peroxidase (EC 1.11.1.7). All of these techniques share the same basic principles with conventional radioimmunoassays.
A somewhat different version of enzyme immunoassay has been reported by Masseyeff et al. (13) for measurement of human IgG, and by Maiolini et al. (14) for measurement of human a-fetoprotein. Their method differs in that antibody rather than antigen is labeled with enzyme; the immunosorbent is antigen covalently bound to Sepharose, and the method is a noncompetitive analysis rather than competitive. In a noncompetitive analysis, an excess of first antibody is used to attempt to bind all the sample antigen being measured in the absence of any labeled antigen. The immunosorbent in this case is used after the first incubation to separate the excess free antibody from antigen/bound-antibody complexes. The enzyme used was glucose oxidase (EC 1.1.3.4) of fungal origin, not found in human tissues, to avoid a potential source of error when the method is applied to human biological material. More recently Maiolini and Masseyeff described yet another version, a "sandwich" method of enzymoimmunoassay for measurement of a-fetoprotein (15) . This assay, a noncompetitive technique, requires antigen, the corresponding antibody immunosorbent, and the corresponding pure antibody labeled with enzyme. The antigen to be measured is sandwiched between insoluble antibody (immunosorbent) and the antibody/enzyme conjugate in a sequential fashion. Interfering substances can be washed away and the final enzymatic activity is measured from the solid phase. Enzymatic activity is directly related to the amount of antigen bound.
Yet another technique of enzyme immunoassay has been reported by Rubenstein et al. (16) , the principle of "EMIT, " a homogeneous enzyme immunoassay technique for the quantitative determination of haptens. It differs quite significantly from the other methods discussed previously. The enzyme is linked covalently to the hapten. When properly prepared, antibody to the hapten will bind the hapten/enzyme conjugate and sterically inhibit enzymatic activity. The hapten to be assayed by this technique will compete for antibody with the hapten/enzyme conjugate, thereby decreasing the inhibition of enzyme activity, and the subsequent increase in enzymatic activity will be proportional to the original amount of hapten present.
The method we present in this paper is a further advance in enzyme immunoassay methodology for the measurement of soluble antigens and haptens. We believe this method of competitive enzyme-linked immunoassay (CELIA), in which an enzyme/antibody soluble immune complex is used as the labeling agent, affords some advantages over the previously reported techniques. For example, this method has the potential for measuring low-molecular-weight haptens as well as larger molecules such as proteins; the other methods have been limited to either one type or the other. Another advantage of the method is that specific covalently linked antigen/enzyme or antibody/enzyme or hapten/enzyme conjugates do not have to be prepared for each individual substance to be assayed. The only unique reagents required for any specific method are the antigen (the substance to be assayed) and the corresponding antibody. The antigen material is linked to a solid-phase material to produce the analogous immunosorbent of previous methods. The binding of antibody to the antigen-immunosorbent is competitively inhibited by the free antigen to be assayed. The enzyme linking is done during the analysis after the initial competitive reaction is terminated. In other words, the amount of first antibody bound to the immunosorbent is measured by an enzymatic technique.
This is accomplished
by the sequential application of a heterologous bridging antibody followed by the application of soluble antibody/enzyme immune complexes. The heterologous bridging antibody is antisera directed against the immunoglobulins from the same species as the first antibody. The use of antibody/enzyme bridging for localization of tissue antigens was first described by Mason et al. (17) .The preparation and use of soluble antibody/enzyme complexes has been described by Sternberger et al. (18) for localization of tissue antigens, and this application is referred to as the "unlabeled antibody enzyme method." Therefore enzyme linking is achieved by additional immune reactions, and the enzyme-linking reagents are potentially of very wide applicability.
We present here a preliminary study of a method for the quantitative determination of HCG in serum and urine to demonstrate the principle of CELIA. In the competitive assay, soluble HCG from the test sample competes with HCG covalently bound to Sepharose (HCG/Sepharose) for binding to rabbit-antiHCGantibody. The amount of antiHCG antibody available for binding to the HCG/Sepharose will of course be diminished by the amount of free HCG in the original sample. The amount of antiHCG antibody bound to Sepharose is then determined by enzyme labeling this complex. Goat anti-rabbit IgG is used as a bridge between the rabbit antiHCG and the soluble rabbit antiperoxidase/peroxidase complex. Thus horseradish peroxidase through additional immune reactions becomes the enzymatic label on the immunosorbent. The peroxidase is subsequently released from the immunosorbent by urea to facilitate the enzymatic assay. Peroxidase activity is inversely proportional to the into New Zealand white rabbits. Five injection sites were used, with a total dose of 2.5 mg per animal. An identical second injection was administered after two weeks and the rabbits were bled at irregular intervals from four to 12 weeks after the first injection. The sera were pooled and stored at -70 #{176}C. The soluble immune complexes of peroxidase and anti-peroxidase were prepared as described by Sternberger (19) . The soluble complexes are stable for at least a year, stored at -70 #{176}C.
Materials and Methods

Preliminary Procedures
Purification of HCG for coupling.
Commercial HCG (A.P.L. brand; Ayerst Laboratories, Inc., New York, N. Y. 10017) was fractionated by ion-exchange chromatography on diethylaminoethyl-Bio-Gel A (100-200 mesh; Bio-Rad Laboratories, Richmond, Calif. 94804) as described by Bahl (20) . The eluted fraction corresponding to HCG was further purified by gel filtration (21) on Sephadex G-150 (Pharmacia, Inc., Piscataway, N. J. 08854). The Sephadex-purified HCG fraction was collected, dialyzed exhaustively against distilled water, and lyophilized. 
HCG/Sepharose, 100
(containing about 0.9 g of HCG), was added to 1.0 ml of soluble HCG solution (standard or sample), followed by the addition of 100 Mlof rabbit anti-HCG (lot No. 1515; ICN Pharmaceuticals, Inc.) at a dilution of 1/1000. The mixture was incubated for 2 h at room temperature with constant stirring (glass-coated magnetic stirring bar). The immunosorbent beads were washed three times each with about 10 ml of phosphate-buffered saline by suspension, centrifugation (1100 X g, 5 mm) and aspiration of the supernate down to a constant volume of 0.5 ml. After the fmal wash, the beads were suspended in 1.0 ml of a 1/400 dilutionof goat anti-rabbitimmunoglobulin G (lot No. 2072; ICN Pharmaceuticals, Inc.). After a 20-mm incubation at room temperature, the HCG/Sepharose was washed as described above. The residual bead suspension was then treated with 0.5 ml of a 1/50 dilution of the anti-peroxidase/peroxidase preparation for a similar 20-mm incubation and was washed four times. The dilutions of goat anti-rabbit immunoglobulin G and anti-peroxidase/peroxidase were made with the phosphate-buffered saline/albumin diluent. After aspiration of the last wash, 2.0 ml of 6 molt liter urea was added to the tube, and the mixture was incubated for 10 min with 0.4 ml of the supernate was transferred to a test tube containing 1.6 ml of 10 mmollliter phosphate buffer (pH 6.0), followed by 2.0 ml of peroxidase substrate (30 mg/liter H2O2 and 80mg/liter o-dianisidine) as described by Avrameas and Guilbert (11), for color development. After exactly 10 mm at room temperature, the reaction was stopped with 0.1 ml of 5 mol/liter HC1 and the absorbance was measured at 400 nm on a Spectronic 100 spectrophotometer (Bausch & Lomb, Inc., Rochester, N. Y. 14625).
The series of reactions that occur, shown diagramatically in Figure 1 The initial incubation time for immunosorbent, free antigen, and antibody was set at 2 h, to limit appropriately the total time required for the procedure. No rate studies were conducted to indicate that the reaction reached a steady-state in this time. Further studies are necessary to optimize this portion of the procedure. The concentration of antibody to be used for the assay was determined by testing serial dilutions of antiHCG under zero standard conditions, the object being to find the limiting concentration that will bind all the available sites on the HCG/Sepharose.
Results of this test are given in Figure 2 . The 1/1000 dilution of our antiHCG preparation was considered optimal, and was used in subsequent competitive-binding assays with this same volume of HCG/Sepharose (100 Ml). An apparent antibody excess reaction was observed at dilutions of less than 1/500, for reasons unexplained.
The amounts of goat anti-rabbit immunoglobulin G and anti-peroxidase/peroxidase should be in excess for the experimental conditions used; both were tested in this system for optimization. The highest dilutions possible were chosen that would give the maximum final absorbance values under zero standard conditions and with the proposed incubation times. Longer incubation times with the proposed amounts of goat anti-rabbit immunoglobulin G and anti-peroxidase/peroxidase did not increase the final absorbance readings. We have not done further studies of shorter incubation times; although it may be possible to shorten these times without losing sensitivity, the amounts of goat anti-rabbit immunoglobulin G and anti-peroxidase/peroxidase may have to be increased. Figure 3 shows the standard curve for HCG. As the amount of added soluble HCG was increased, the intensity of the color reaction decreased progressively. The working range of the assay was from 1 to 50 mt. units/ml of sample. The dialyzed commercial HCG used as a standard was equivalent to the International Reference Preparation of HCG by radioimmunoassay. Conversely, when the reference material was assayed by CELIA, the expected values were obtained. The serum from a patient with choriocarcinoma was diluted to test for parallelism. As shown in Figure 3 , curves for standard and choriocarcinoma serum coincide. The within-run coefficient of variation of the method, as determined by 24 replicate analyses of a 4 mt. unit/ml standard, was 9.6%. As a preliminary evaluation of the clinical applicability of the CELIA method, HCG was measured in five sera and five urine samples and the results compared to results obtained by radioimmunoassay (Figure 4) .
Discussion
There units/mi. The correlation coefficient for these points is 0.989 with P < 0.0005.
The standard error of the estimate is 11 mt. unIts/mi methods mentioned above require a specific enzymecoupled reagent for each individual substance to be measured. Prior to the assay, these methods require that the first antigen, antibody, or hapten associated with the competitive or immuno-reaction must be covalently coupled to the enzyme label.CELIA, however, has the distinct advantage of not requiringprior couplingof the enzyme label.Since the goat anti-rabbitimmunoglobulin G willrecognize any rabbit antibody and bridge between the first antibody and the rabbit antibody in the anti-peroxidase/peroxidase, CELIA offers the advantage of allowing the use of goat anti-rabbit immunoglobulin G and anti-peroxidase/peroxidase as reagents for different antigen assays. The enzyme-linking reagents are therefore the same, regardless of the specific substance being assayed. For example, in the HCG assay presented here, rabbit antisera to HCG is used as the first antibody followed by goat anti-rabbit-IgG followed by rabbit anti-peroxidase/peroxidase complex.
Because many different rabbit antibodies as well as the goat anti-rabbit immunoglobulin G and anti-peroxidase/peroxidase are commercially available, the method can be readily applied to the measurement of many other substances. CELIA obviates the more difficult covalentcouplingsofantigenor antibody to enzyme and the subsequent purification steps required by the other methods. The EMIT methodology isparticularlycumbersome in this respect, because not only does the enzyme used have to be coupled with the hapten, but the coupling has to critically position a number of haptens on the enzyme in order that the activity of the enzyme willbe inhibitedwhen the hapten/enzyme conjugate is bound to antibody.
Some of the earliermethods are more susceptibleto endogenous interferences or inhibitors than is the CELIA method, in which the enzyme label is not introduced untilafterthe soluble sample components are removed by washing, thereby completely eliminatingthe possibility of any sample interferences.
In the EMIT method one has to be concerned about the presence of endogenous enzymes similar to the enzyme used as label, because the entire assay is done in the presence of sample. The lysozyme (EC 3.2.1.17) label used in some of the EMIT urine assays cannot be used in serum samples for this reason, and, although rare,some patients'urine contains lysozyme. EMIT istheoretically susceptibleto enzyme inhibitors and other interferents that might be present in the sample. In most of the enzyme-linked immunosorbent assay techniques and the noncompetitive sandwich methods, the possibility of endogenous enzyme interference, enzyme inhibition, or other sample interference is minimized, because separation of the sample supernate from solid-phase-bound enzyme usually involves a washing step. However, because the enzyme label does come in contact with the specimen, it would theoretically be possible for an irreversible inhibitor to interfere with the test. Other techniques (10) (11) (12) (13) (14) do not involve a wash step and so are potentially susceptible to specimen interferences and inhibitors. CELIA is potentially applicable to the measurement of both low-and high-molecular-weight haptens. We have successfully applied the principle of CELIA to the measurement of testosterone, and this topic will be the subject of a future publication. This multiple binding has been described by Sternberger et al. (18, 19) and has been proposed as the reason for the observed increased sensitivity of the "unlabeled antibody enzyme method" when anti-peroxidase/peroxidaseisused rather than immunofluorescence and other peroxidase methods for localizing tissueantigen. In addition,the efficiency of covalentlylinkingenzyme to immunoglobulin is quite low (yieldson the order of 4%) for glutaraldehydeconjugating procedures (19) . In the HCG assay described, sensitivity could be easily increased by increasing the enzymatic reaction time and by preincubating the sample with anti-HCG before introducing the HCG/Sepharose as in a sequential competitive protein-binding analysis.
The noncompetitive sandwich technique described by Maiolini and Masseyeff (15) and the other noncompetitive methods all suffer the disadvantage of depending on the purity of the antibody. If antibody is not pure, something other than the antigen to be assayed will be measured. CELIA does not require pure antibody, and in fact commercial antisera are quite acceptable. The authors of the sandwich technique also discovered that rheumatoid factor gives false-positive reactions by bridging between the two antibodies without the presence of antigen. The sandwich technique also will not work for haptens that are univalent.
A variation of CELIA can be used to titrate serial dilutions of serum antibodies without competition by putting the antigen on the solid phase. For example, titers of antibodies in autoimmune diseases such as antinuclear antibodies or of antibacterial antibodies can be determined.
The resulting antigen/antibody complexes can be measured by the described enzyme-linking process and subsequent activity measurement.
CELIA therefore is a new method of enzyme immunoassay for the measurement of soluble haptens and antigens. It offers a simpler methodology than previous methods with respect to preparation of reagents and is potentially universal in its application.
